APVO - Aptevo Therapeutics EPS misses by $0.04 beats on revenue August, 09 2019 09:04 AM Aptevo Therapeutics Inc. Aptevo Therapeutics (NASDAQ:APVO): Q2 GAAP EPS of -$0.30 misses by $0.04.More news on: Aptevo Therapeutics Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...